Mark Newton, chief technical analyst at Greywolf Execution Partners, shares his top investment idea for the months ahead.» Read More
CNBC's Jim Cramer has had a change in heart about when the Fed should raise rates after seeing more positive economic data.
Eight were scheduled to price overnight, and so far only six have made it.
The improved fiscal health of states is due to a wave of cuts that have whittled away at pension benefits for current and future retirees.
Oscar Schafer, chairman of Rivulet Capital, is making a bet that shares of a small-cap biotech company will rally.
There's a bubble building in the bond market, market analyst Peter Boockvar tells CNBC. "Air is slowing coming out."
Jim Cramer warns investors that a split is not a good reason to own a stock; it's just cosmetic.
The "Fast Money" traders give their final trades of the day.
Credit card holders are largely ambivalent about earning points, miles or cash back on their card purchases, a Bankrate survey found.
Past performance in fact does seem to provide a good indicator of future results, just not in the way you might think.
Jim Cramer found one under-the-radar stock in every U.S. kitchen, that is about to have phenomenal growth.
Despite Carl Icahn's warning on the market, several pros said things were looking good and there was nothing to panic about.
Here's why Pimco's Mark Kiesel doesn't see a risk right now for the high-yield bond market and why he still likes housing.
Take a look at some of Wednesday's after-hours buzz: MLHR, BBBY, CREE & more
Carl Icahn warned investors that he believes the market is "extremely overheated—especially high-yield bonds."
A day after Netflix announced a 7-for-1 stock split, Icahn said he sold his remaining shares.
Let's make a deal! The five keys to a successful business deal, according to Marcus Lemonis, entrepreneur and host of "The Profit."
Technical analyst Rich Ross explains why Monster shares could rally more than 8 percent in the near future.
Investors are flocking to health-care stocks, and one trader is betting on big returns from drug company Pfizer.
History shows the U.S. stock market has more or less been able to take the fears about potential Greece default and crisis in stride.
Volatility has suffered a "rolling crash" of late. That's not great for traders, but investors should cheer.